Tandem announces FDA approval of their new Mobi insulin pump.
Tandem has announced FDA approval of their new Mobi insulin pump. The new system has similar features to Tandem’s T:Slim pump, including Control IQ (automated insulin delivery) technology.
However, there are several important differences:
The differences between the Tandem T:Slim and Mobi insulin pumps.
Mobi is about half the size of the T:Slim
The cartridge holds up to 200 units of insulin
The pump has only one button (for delivering boluses in fixed increments). All other programming is performed via an iPhone mobile app
Any Tandem infusion set can be used, but there is also a 5” tubing option
The pump can placed in a sleeve for adhering directly to the skin (a clip option is also available)
It can be charged wirelessly
Mobi is approved for ages 6 and up. Those who purchase a Tandem T:Slim pump between now and the end of 2023 can upgrade to Mobi for $199 once it becomes available. Those using other pumps (including current T:Slim users) can switch to Mobi for $999 as long as there is sufficient time remaining on the current pump’s warranty.
Integrated Diabetes Services is the worldwide leader in one-on-one consulting for people who use insulin. Diabetes “coaching” services are available in-person and remotely via phone and the internet for children and adults.